Synapse by Bioscript Data Insights enables data-driven decision-making
Bioscript Group, a scientific communications agency, has today announced the launch of Synapse by Bioscript Data Insights (BDI), an AI-augmented platform designed to help medical affairs teams make predictions and transform complex scientific and medical insight into evidence-backed decisions.
Medical affairs teams track abstracts, congresses, healthcare provider (HCP) video channels, key opinion leaders (KOLs), and social signals to support evidence planning, communication strategies, and medical education. This overwhelming volume of fragmented data means valuable insights are rarely converted into behavioural change, and the same activities are continually repeated.
Unlike traditional platforms that operate in silos, Synapse by BDI offers a fully integrated view that encompasses congress trends, KOL shifts, and competitor moves to reveal early signals and strategic gaps. It doesn’t just present data; it guides behaviour with tailored, context-specific recommendations.
Synapse has already helped one organisation demonstrate the value delivered by its Medical Science Liaison team. Measuring scientific share of voice and engagement, and analysing congress activity, publication metrics, and HCP integration data to create a robust ROI model, the platform delivered a comprehensive dashboard showing MSL impact on scientific engagement, and identifying gaps and opportunities to secure budget for three additional MSLs.
Gabrielle Silver, CEO, Bioscript Group said: “Demonstrating the success of a project or ROI is crucial for gaining buy-in to justify future investment. Synapse by BDI enables data-driven decision-making, backed by clear evidence.
“Synapse by BDI has been designed specifically to help medical affairs teams not just gather insights—but predict, prioritise, and act in ways that change behaviour, said James Wright, Senior Director at Bioscript Group.
“For too long, medical affairs teams have had to wade through too much noise. Our new platform enables teams to deploy resources effectively with clarity and avoid repetitive, low-impact engagement strategies.”
Synapse by BDI integrates congress intelligence, KOL activity, publication trends, and competitive insights into a single intuitive platform. Its key capabilities include:
- Congress intelligence: Pre, during, and post-event, and complete insights delivered within 48 hours of event wrap-up.
- KOL recommender and predictive behaviour mapping
- Evidence generation & competitive intelligence
- Predictive publication planning
- Medical Science Liaisons (MSLs) insights mining
A fully integrated, intuitive platform, Synpase by BDI is meticulously designed to support both global strategy and on-the-ground execution, adapting to clients’ unique needs and delivering tailored insights that drive success.
About Bioscript Group
Bioscript Group is a global medical communications and strategy partner, supporting pharma and biotech companies in delivering impactful scientific engagement across the product lifecycle. Its dedicated data division, Bioscript Data Insights, blends domain expertise with advanced analytics to unlock smarter decision-making in medical affairs.
